Paraoxsonase2 (PON2) and oxidative stress involvement in pomegranate juice protection against cigarette smoke-induced macrophage cholesterol accumulation

Chemico-Biological Interactions

Volumn 259, Issue , 2016, Pages 394-400

  Rom, Oren ^a   Aviram, Michael ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Cholesterol; Cigarette smoke; Macrophages; Oxidative stress; Paraoxonase2; Pomegranate juice

Indexed keywords

ARYLDIALKYLPHOSPHATASE 2; CHOLESTEROL; CIGARETTE SMOKE; HIGH DENSITY LIPOPROTEIN; LIPID PEROXIDE; REACTIVE OXYGEN METABOLITE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; ARYLDIALKYLPHOSPHATASE; LOW DENSITY LIPOPROTEIN; PROTECTIVE AGENT;

ANIMAL CELL; ARTICLE; ASSAY; ATHEROGENESIS; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; LIPID METABOLISM; LIPID PEROXIDATION; LIPID PEROXIDES ASSAY; LIPID STORAGE; MACROPHAGE; MOUSE; NONHUMAN; OXIDATION; OXIDATIVE STRESS; POMEGRANATE JUICE; PROTECTION; THIOBARBITURIC ACID REACTIVE SUBSTANCES ASSAY; ADVERSE EFFECTS; ANIMAL; BEVERAGE; CELL LINE; CHEMISTRY; DRUG EFFECTS; ENZYMOLOGY; LYTHRACEAE; METABOLISM; OXIDATION REDUCTION REACTION; PATHOLOGY; SMOKING;

ANIMALS; ARYLDIALKYLPHOSPHATASE; BEVERAGES; CELL LINE; CHOLESTEROL; LIPID PEROXIDATION; LIPOPROTEINS, LDL; MACROPHAGES; MICE; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTECTIVE AGENTS; PUNICACEAE; SMOKING;

EID: 84966670917     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2016.05.009     Document Type: Article

References (41)

1. [1] Mozaffarian, D., Benjamin, E.J., Go, A.S., Arnett, D.K., Blaha, M.J., Cushman, M., de Ferranti, S., Després, J.P., Fullerton, H.J., Howard, V.J., Huffman, M.D., Judd, S.E., Kissela, B.M., Lackland, D.T., Lichtman, J.H., Lisabeth, L.D., Liu, S., Mackey, R.H., Matchar, D.B., McGuire, D.K., Mohler, E.R. 3rd, Moy, C.S., Muntner, P., Mussolino, M.E.E., Nasir, K., Neumar, R.W., Nichol, G., Palaniappan, L., Pandey, D.K., Reeves, M.J., Rodriguez, C.J., Sorlie, P.D., Stein, J., Towfighi, A., Turan, T.N., Virani, S.S., Willey, J.Z., Woo, D., Yeh, R.W., Turner, M.B., Heart disease and stroke statistics – 2015 update: a report from the American Heart Association. Circulation 131 (2015), e29–322.
2. [2] Frostegård, J., SLE, atherosclerosis and cardiovascular disease. Intern. Med. 257 (2005), 485–495.
3. [3] Messner, B., Bernhard, D., Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis. Arterioscler. Thromb. Vasc. Biol. 34 (2014), 509–515.
4. [4] Ambrose, J.A., Barua, R.S., The pathophysiology of cigarette smoking and cardiovascular disease: an update. J. Am. Coll. Cardiol. 43 (2004), 1731–1737.
5. [5] Swan, G.E., Lessov-Schlaggar, C.N., The effects of tobacco smoke and nicotine on cognition and the brain. Neuropsychol. Rev. 17 (2007), 259–273.
6. [6] Rom, O., Kaisari, S., Aizenbud, D., Reznick, A.Z., Identification of possible cigarette smoke constituents responsible for muscle catabolism. J. Muscle. Res. Cell Motil. 33 (2012), 199–208.
7. [7] Tostes, R.S., Carneiro, F.S., Lee, A.J., Giachini, F.R., Leite, R., Osawa, Y., Webb, R.C., Cigarette smoking and erectile dysfunction: focus on NO bioavailability and ROS generation. J. Sex. Med. 5 (2008), 1284–1295.
8. [8] Dickhout, J.G., Basseri, S., Austin, R.C., Macrophage function and its impact on atherosclerotic lesion composition, progression, and stability: the good, the bad, and the ugly. Arterioscler. Thromb. Vasc. Biol. 28 (2008), 1413–1415.
9. [9] Rosenblat, M., Aviram, M., Paraoxonases role in the prevention of cardiovascular diseases. Biofactors 35 (2009), 98–104.
10. [10] Seeram, N.P., Aviram, M., Zhang, Y., Henning, S.M., Feng, L., Dreher, M., Heber, D., Comparison of antioxidant potency of commonly consumed polyphenol-rich beverages in the United States. J. Agric. Food Chem. 56 (2008), 1415–1422.
11. [11] Fuhrman, B., Aviram, M., Flavonoids protect LDL from oxidation and attenuate atherosclerosis. Curr. Opin. Lipidol. 12 (2001), 41–48.
12. [12] Aviram, M., Rosenblat, M., Pomegranate protection against cardiovascular diseases. Evid. Based Complement. Altern. Med., 2012, 2012, 382763.
13. [13] Aviram, M., Dornfeld, L., Rosenblat, M., Volkova, N., Kaplan, M., Coleman, R., Hayek, T., Presser, D., Fuhrman, B., Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am. J. Clin. Nutr. 71 (2000), 1062–1076.
14. [14] Fuhrman, B., Volkova, N., Aviram, M., Pomegranate juice inhibits oxidized LDL uptake and cholesterol biosynthesis in macrophages. J. Nutr. Biochem. 16 (2005), 570–576.
15. [15] Kaplan, M., Hayek, T., Raz, A., Coleman, R., Dornfeld, L., Vaya, J., Aviram, M., Pomegranate juice supplementation to atherosclerotic mice reduces macrophage lipid peroxidation, cellular cholesterol accumulation and development of atherosclerosis. J. Nutr. 131 (2001), 2082–2089.
16. [16] Aviram, M., Dornfeld, L., Kaplan, M., Coleman, R., Gaitini, D., Nitecki, S., Hofman, A., Rosenblat, M., Volkova, N., Presser, D., Attias, J., Hayek, T., Fuhrman, B., Pomegranate juice flavonoids inhibit low-density lipoprotein oxidation and cardiovascular diseases: studies in atherosclerotic mice and in humans. Drugs Exp. Clin. Res. 28 (2002), 49–62.
17. [17] Reddy, S.T., Devarajan, A., Bourquard, N., Shih, D., Fogelman, A.M., Is it just paraoxonase 1 or are other members of the paraoxonase gene family implicated in atherosclerosis?. Curr. Opin. Lipidol. 19 (2008), 405–408.
18. [18] Shiner, M., Fuhrman, B., Aviram, M., A biphasic U-shape effect of cellular oxidative stress on the macrophage anti-oxidant paraoxonase 2 (PON2) enzymatic activity. Biochem. Biophys. Res. Commun. 349 (2006), 1094–1109.
19. [19] Rosenblat, M., Draganov, D., Watson, C.E., Bisgaier, C.L., La Du, B.N., Aviram, M., Mouse macrophage paraoxonase 2 activity is increased whereas cellular paraoxonase 3 activity is decreased under oxidative stress. Arterioscler. Thromb. Vasc. Biol. 23 (2003), 468–474.
20. [20] Aviram, M., Rosenblat, M., Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development. Free Radic. Biol. Med. 37 (2004), 1304–1316.
21. [21] Rom, O., Kaisari, S., Aizenbud, D., Reznick, A.Z., Cigarette smoke and muscle catabolism in C2 myotubes. Mech. Ageing Dev. 134 (2013), 24–34.
22. [22] Kaisari, S., Rom, O., Aizenbud, D., Reznick, A.Z., Involvement of NF-κB and muscle specific E3 ubiquitin ligase MuRF1 in cigarette smoke-induced catabolism in C2 myotubes. Adv. Exp. Med. Biol. 788 (2013), 7–17.
23. [23] Gil, M.I., Tomás-Barberán, F.A., Hess-Pierce, B., Holcroft, D.M., Kader, A.A., Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. J. Agric. Food Chem. 48 (2000), 4581–4589.
24. [24] Zhang, Y., Krueger, D., Durst, R., Lee, R., Wang, D., Seeram, N., Heber, D., International multidimensional authenticity specification (IMAS) algorithm for detection of commercial pomegranate juice adulteration. J. Agric. Food. Chem. 57 (2009), 2550–2557.
25. [25] Ben Nasr, C., Ayed, N., Metche, M., Quantitative determination of the polyphenolic content of pomegranate peel. Z. Leb. Unters. Forsch. 203 (1996), 374–378.
26. [26] Buege, J.A., Aust, S.D., Microsomal lipid peroxidation. Methods Enzymol. 52 (1978), 302–310.
27. [27] El-Saadani, M., Esterbauer, H., El-Sayed, M., Goher, M., Nassar, A.Y., Jürgens, G., A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J. Lipid. Res. 30 (1989), 627–630.
28. [28] Yuan, F., Dong, P., Wang, X., Fu, X., Dai, M., Zhang, W., Toxicological effects of cigarette smoke on Ana-1 macrophages in vitro. Exp. Toxicol. Pathol. 65 (2013), 1011–1018.
29. [29] Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.J., Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951), 265–275.
30. [30] Aviram, M., Plasma lipoprotein separation by discontinuous density gradient ultracentrifugation in hyperlipoproteinemic patients. Biochem. Med. 30 (1983), 111–118.
31. [31] James, R.W., Leviev, I., Righetti, A., Smoking is associated with reduced serum paraoxonase activity and concentration in patients with coronary artery disease. Circulation 101 (2000), 2252–2257.
32. [32] Nishio, E., Watanabe, Y., Cigarette smoke extract inhibits plasma paraoxonase activity by modification of the enzyme's free thiols. Biochem. Biophys. Res. Commun. 18 (1997), 289–293.
33. [33] Rosenblat, M., Coleman, R., Reddy, S.T., Aviram, M., Paraoxonase 2 attenuates macrophage triglyceride accumulation via inhibition of diacylglycerol acyltransferase 1. J. Lipid. Res. 50 (2009), 870–879.
34. [34] Rosenblat, M., Aviram, M., Pomegranate juice protects macrophages from triglyceride accumulation: inhibitory effect on DGAT1 activity and on triglyceride biosynthesis. Ann. Nutr. Metab. 58 (2011), 1–9.
35. [35] Rosenblat, M., Volkova, N., Aviram, M., Pomegranate juice (PJ) consumption antioxidative properties on mouse macrophages, but not PJ beneficial effects on macrophage cholesterol and triglyceride metabolism, are mediated via PJ-induced stimulation of macrophage PON2. Atherosclerosis 212 (2010), 86–92.
36. [36] Ueyama, K., Yokode, M., Arai, H., Nagano, Y., Li, Z.X., Cho, M., Kita, T., Cholesterol efflux effect of high density lipoprotein is impaired by whole cigarette smoke extracts through lipid peroxidation. Free Radic. Biol. Med. 24 (1998), 182–190.
37. [37] Marcil, V., Delvin, E., Sané, A.T., Tremblay, A., Levy, E., Oxidative stress influences cholesterol efflux in THP-1 macrophages: role of ATP-binding cassette A1 and nuclear factors. Cardiovasc. Res. 72 (2006), 473–482.
38. [38] Song, W., Wang, W., Dou, L.Y., Wang, Y., Xu, Y., Chen, L.F., Yan, X.W., The implication of cigarette smoking and cessation on macrophage cholesterol efflux in coronary artery disease patients. J. Lipid Res. 56 (2015), 682–691.
39. [39] Zong, C., Song, G., Yao, S., Guo, S., Yu, Y., Yang, N., Guo, Z., Qin, S., Cigarette smoke exposure impairs reverse cholesterol transport which can be minimized by treatment of hydrogen-saturated saline. Lipids Health Dis., 14, 2015, 159.
40. [40] Mol, M.J., de Rijke, Y.B., Demacker, P.N., Stalenhoef, A.F., Plasma levels of lipid and cholesterol oxidation products and cytokines in diabetes mellitus and cigarette smoking: effects of vitamin E treatment. Atherosclerosis 129 (1997), 169–176.
41. [41] Scalbert, A., Williamson, G., Dietary intake and bioavailability of polyphenols. J. Nutr. 130 (2000), 2073S–2085S.